Trials / Withdrawn
WithdrawnNCT05023512
Understanding Public Attitudes Towards the COVID-19 Vaccination
Together Researching Understanding, Solidarity, and Trust Around COVID - TRUST Study
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of Massachusetts, Worcester · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to better understand public attitudes towards coronavirus disease 2019 (COVID-19) vaccination. This understanding will inform the development of community engagement strategies to be used in future interventions and studies aimed at addressing factors that impact the disproportionate burden of COVID-19 in under-served and vulnerable communities.
Detailed description
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly instigated a global pandemic. As of this writing, there are more than 33 million documented cases of infection in the United States (US). Furthermore, in the US, COVID-19 has disrupted the economy, overwhelmed the healthcare system, led to widespread school cancellations, and caused more than 595,000 deaths since March 2020. The availability of three highly effective vaccines against COVID-19 within a year of the start of the pandemic is an extraordinary achievement and cause for great optimism. However, a significant proportion of adults in the U.S. have not accepted vaccination against COVID-19. Efforts are needed to identify effective messages and communication strategies to overcome COVID-19 vaccine hesitancy. To address this need, the investigators plan to conduct two rapid surveys among Massachusetts residents, to assess attitudes towards COVID-19 vaccination.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Communication about the COVID-19 vaccination from the Massachusetts Department of Public Health | Participants will be randomized to receive one of two different versions of messages from the Massachusetts Department of Public Health. The message that participants in each experimental group receive will vary slightly and systematically. Specific content and wording of these messages were developed to address and mitigate concerns about the Covid-19 vaccination. |
Timeline
- Start date
- 2021-10-28
- Primary completion
- 2022-07-15
- Completion
- 2022-09-01
- First posted
- 2021-08-26
- Last updated
- 2022-06-06
Source: ClinicalTrials.gov record NCT05023512. Inclusion in this directory is not an endorsement.